3-191358113-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_178335.3(CCDC50):​c.228C>T​(p.Arg76Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.308 in 1,613,326 control chromosomes in the GnomAD database, including 77,612 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 6804 hom., cov: 31)
Exomes 𝑓: 0.31 ( 70808 hom. )

Consequence

CCDC50
NM_178335.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0720

Publications

20 publications found
Variant links:
Genes affected
CCDC50 (HGNC:18111): (coiled-coil domain containing 50) This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
CCDC50 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 44
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 3-191358113-C-T is Benign according to our data. Variant chr3-191358113-C-T is described in ClinVar as Benign. ClinVar VariationId is 48153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.072 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.32 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CCDC50NM_178335.3 linkc.228C>T p.Arg76Arg synonymous_variant Exon 3 of 12 ENST00000392455.9 NP_848018.1
CCDC50NM_174908.4 linkc.228C>T p.Arg76Arg synonymous_variant Exon 3 of 11 NP_777568.1
CCDC50XM_011512460.2 linkc.228C>T p.Arg76Arg synonymous_variant Exon 3 of 8 XP_011510762.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CCDC50ENST00000392455.9 linkc.228C>T p.Arg76Arg synonymous_variant Exon 3 of 12 1 NM_178335.3 ENSP00000376249.4
CCDC50ENST00000392456.4 linkc.228C>T p.Arg76Arg synonymous_variant Exon 3 of 11 1 ENSP00000376250.4

Frequencies

GnomAD3 genomes
AF:
0.299
AC:
45350
AN:
151782
Hom.:
6791
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.231
Gnomad AMR
AF:
0.306
Gnomad ASJ
AF:
0.368
Gnomad EAS
AF:
0.249
Gnomad SAS
AF:
0.226
Gnomad FIN
AF:
0.332
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.323
Gnomad OTH
AF:
0.313
GnomAD2 exomes
AF:
0.302
AC:
75895
AN:
250986
AF XY:
0.299
show subpopulations
Gnomad AFR exome
AF:
0.255
Gnomad AMR exome
AF:
0.322
Gnomad ASJ exome
AF:
0.366
Gnomad EAS exome
AF:
0.250
Gnomad FIN exome
AF:
0.326
Gnomad NFE exome
AF:
0.320
Gnomad OTH exome
AF:
0.311
GnomAD4 exome
AF:
0.309
AC:
451791
AN:
1461426
Hom.:
70808
Cov.:
36
AF XY:
0.307
AC XY:
223342
AN XY:
727028
show subpopulations
African (AFR)
AF:
0.248
AC:
8285
AN:
33460
American (AMR)
AF:
0.323
AC:
14454
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.365
AC:
9525
AN:
26122
East Asian (EAS)
AF:
0.208
AC:
8258
AN:
39690
South Asian (SAS)
AF:
0.240
AC:
20721
AN:
86256
European-Finnish (FIN)
AF:
0.325
AC:
17355
AN:
53400
Middle Eastern (MID)
AF:
0.239
AC:
1379
AN:
5762
European-Non Finnish (NFE)
AF:
0.318
AC:
353519
AN:
1111668
Other (OTH)
AF:
0.303
AC:
18295
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
16652
33304
49955
66607
83259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11436
22872
34308
45744
57180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.299
AC:
45414
AN:
151900
Hom.:
6804
Cov.:
31
AF XY:
0.300
AC XY:
22270
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.258
AC:
10688
AN:
41424
American (AMR)
AF:
0.307
AC:
4677
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.368
AC:
1275
AN:
3468
East Asian (EAS)
AF:
0.249
AC:
1284
AN:
5156
South Asian (SAS)
AF:
0.226
AC:
1081
AN:
4780
European-Finnish (FIN)
AF:
0.332
AC:
3510
AN:
10572
Middle Eastern (MID)
AF:
0.265
AC:
78
AN:
294
European-Non Finnish (NFE)
AF:
0.323
AC:
21948
AN:
67932
Other (OTH)
AF:
0.314
AC:
663
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1607
3214
4821
6428
8035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.315
Hom.:
6575
Bravo
AF:
0.300
Asia WGS
AF:
0.279
AC:
968
AN:
3478
EpiCase
AF:
0.318
EpiControl
AF:
0.312

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg76Arg in Exon 03 of CCDC50: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 32.0% (2245/7020) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs11542549).

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
12
DANN
Benign
0.69
PhyloP100
0.072
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11542549; hg19: chr3-191075902; COSMIC: COSV66667449; COSMIC: COSV66667449; API